MEDI4736
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for MEDI4736, covering 2018-03-16 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours [Phase 1]